NAMI SCC Website

    

 

 

 

 

 

 

 

 

Guest Book
Home
About
HELP
Search
Site Map
Links
Advocacy
Events
Experiences
News
Newsletters
Opinion
People
Recovery
Research
Santa Cruz

 

Children's Mental Health Site of the Month

 

 

 

CAMH Clinical Trial on Aripiprazole 

Aripiprazole, a new antipsychotic drug made by Bristol-Meyers Squibb, is now being tested in Toronto's notorious Centre for Addiction & Mental Health (CAMH) to see if it's more effective then Perphanazine. The study is being conducted by Dr Roy McCurley and co-investigator Dr. Pablo Diaz.  The 'study coordinator' is Hesther Tims. The CAMH tel# 416-535-8501 - McCurley's ext. 2121, Diaz's ext. 2743, Tims' ext. 2062. 

Here's the opening statement on the PR News release: 

"Aripiprazole is a new antipsychotic medication developed by Bristol-Meyers Squibb for the treatment of people with schizophrenia. In this research study the safety and effectiveness of Aripiprazole will be compared to another anti-psychotic medication (Perphenazine)." this study has two 6-week phases."

CAMH has been accused by the antipsychiatry movement of incompetent and biased research heavily funded by drug companies.   A few months ago, the University of Toronto and CAMH refused to hire biopsychiatrist-researcher David Healy who committed the crime of simply stating in a public lecture last winter that Prozac can make people more depressed or suicidal - a well-documented, widely-known fact during the last 10 years! (Click here for article)

More on Aripiprazole...

Home Alerts Experiences News Recovery Research Editorial Links Site Map Search Santa Cruz Guest Book

Opinions expressed in this web site do not necessarily reflect the views of NAMI Santa Cruz County, NAMI California or any affiliated organizations.  We attempt to present a balanced perspective on issues by presenting multiple viewpoints.

Copyright 2005 National Alliance for the Mentally Ill Santa Cruz County, All Rights Reserved.

FAIR USE NOTICE: This may contain copyrighted (©) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml  If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.